 Excessive osteoclast leads to the imbalance in bone reconstruction and results in osteolytic diseases such as osteoporosis and rheumatic arthritis . Integrin

@highlight Tablysin 15 inhibits the formation and bone resorption of osteoclast.
@highlight Tablysin 15 inhibits the
@highlight None
@highlight  FAK NF B MAPK and Akt NFATc1 signaling pathways.
@highlight In vivo Tablysin 15 inhibits LPS induced bone loss.
